ARK Investment Management IONIS PHARMACEUTICALS ownership

IONIS PHARMACEUTICALS's ticker is IONS and the CUSIP is 462222100. A total of 42 filers reported holding IONIS PHARMACEUTICALS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

ARK Investment Management ownership history of IONIS PHARMACEUTICALS
ValueSharesWeighting
Q2 2022$171,691
-24.9%
4,701,297
-23.8%
1.02%
+6.4%
Q1 2022$228,585
+6.1%
6,171,308
-12.9%
0.95%
+46.3%
Q4 2021$215,543
-24.5%
7,083,256
-16.8%
0.65%
-5.0%
Q3 2021$285,472
-19.7%
8,511,384
-4.4%
0.69%
+3.8%
Q2 2021$355,329
+53.7%
8,907,733
+73.2%
0.66%
+44.0%
Q1 2021$231,197
+70.4%
5,142,271
+114.3%
0.46%
+27.1%
Q4 2020$135,671
+468.9%
2,399,554
+377.5%
0.36%
+156.0%
Q3 2020$23,846
+17.5%
502,560
+46.0%
0.14%
-35.3%
Q2 2020$20,290
+258.5%
344,131
+187.5%
0.22%
+54.6%
Q1 2020$5,659
-56.6%
119,681
-44.6%
0.14%
-57.1%
Q4 2019$13,050
+10.8%
216,025
+9.8%
0.33%
+28.0%
Q3 2019$11,782
+16.2%
196,669
+24.7%
0.26%
+0.8%
Q2 2019$10,140
-24.3%
157,773
-4.4%
0.26%
-33.4%
Q1 2019$13,391
+2.2%
164,978
-31.9%
0.38%
-28.0%
Q4 2018$13,099
+10.7%
242,312
+5.7%
0.53%
+49.0%
Q3 2018$11,828
+33.2%
229,318
+7.6%
0.36%
+9.8%
Q2 2018$8,881
-42.7%
213,127
-39.4%
0.32%
-57.8%
Q1 2018$15,512
-16.8%
351,905
-5.1%
0.77%
-48.2%
Q4 2017$18,653
+107.2%
370,835
+109.5%
1.49%
-15.2%
Q2 2017$9,004
+75.6%
176,991
+38.7%
1.75%
+18.6%
Q1 2017$5,128
+1517.7%
127,563
+1826.6%
1.48%
+1185.2%
Q4 2016$3176,6210.12%